The starting dose of 30 μg/kg every 4 weeks was selected because a clear trend of REG3A upregulation at this level was observed in the phase 1a trial.
← all excerpts
Dose escalation randomised study of efmarodocokin alfa in healthy volunteers and patients with ulcerative colitis.
1
—
—